These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. [Chronic myeloid leukemia treated with busulfan. Clinical characteristics, prognostic factors, effect of treatment and survival in 82 cases]. Larrain C; Cruz A; Codoceo V Rev Med Chil; 1984 Sep; 112(9):898-911. PubMed ID: 6598227 [No Abstract] [Full Text] [Related]
26. [Metastasis to the pituitary stalk in a case of breast cancer]. Delattre JY; Castelain C; Davila L; Schadeck B; Poisson M Rev Neurol (Paris); 1990; 146(6-7):455-6. PubMed ID: 2204991 [TBL] [Abstract][Full Text] [Related]
28. Diabetes insipidus in a child with erythromyelocytic leukemia. Roy S; Johnson WW Am J Dis Child; 1970 Jan; 119(1):82-5. PubMed ID: 5262250 [No Abstract] [Full Text] [Related]
29. Pituitary insufficiency after penetrating injury to the sella turcica. Kusanagi H; Kogure K; Teramoto A J Nippon Med Sch; 2000 Apr; 67(2):130-3. PubMed ID: 10754603 [TBL] [Abstract][Full Text] [Related]
30. Diabetes insipidus and breast cancer. Yap HY; Tashima CK; Blumenschein GR; Eckles N Arch Intern Med; 1979 Sep; 139(9):1009-11. PubMed ID: 475518 [TBL] [Abstract][Full Text] [Related]
31. Suprasellar ectopic pituitary adenoma presenting as cranial diabetes insipidus. Luk KH; Lam KS; Kung AW; Fung CF; Leung SY Postgrad Med J; 1992 Jun; 68(800):467-9. PubMed ID: 1437932 [TBL] [Abstract][Full Text] [Related]
32. Systemic cancer presenting as diabetes insipidus. Clinical and radiographic features of 11 patients with a review of metastatic-induced diabetes insipidus. Kimmel DW; O'Neill BP Cancer; 1983 Dec; 52(12):2355-8. PubMed ID: 6640507 [TBL] [Abstract][Full Text] [Related]
33. Prolonged busulfan-induced remissions in chronic myeloid leukemia. Benjamin D; Djaldetti M; Mammon Z; Shaklai M; Pinkhas J Acta Haematol; 1979; 62(2):119-20. PubMed ID: 119401 [TBL] [Abstract][Full Text] [Related]
34. Treatment of chronic myeloid leukemia with repeated single doses of busulfan. Sullivan JR; Hurley TH; Bolton JH Cancer Treat Rep; 1977; 61(1):43-5. PubMed ID: 266418 [TBL] [Abstract][Full Text] [Related]
36. Blastic crisis and myelofibrosis, simultaneous complications in a case of chronic myelocytic leukemia. Hassan K J Pak Med Assoc; 1981 Jul; 31(7):151-3. PubMed ID: 6792398 [No Abstract] [Full Text] [Related]
37. Recovery from diabetes insipidus associated with AML after a BMT conditioning regimen including busulfan. Pagano L; Voso MT; Sica S; Leone G Bone Marrow Transplant; 1993 Feb; 11(2):175-6. PubMed ID: 8435667 [TBL] [Abstract][Full Text] [Related]
38. [Pulmonary fibrosis after busulfan therapy]. Jandl H; Franke A; Albrecht G Z Gesamte Inn Med; 1975 Dec; 30(24):799-801. PubMed ID: 1062873 [TBL] [Abstract][Full Text] [Related]
39. Chronic granulocytic leukemia: long-term remission in a patient with familial sarcoidosis. Cheng DS; Kitahara M; Logan KH South Med J; 1979 Jun; 72(6):645-7. PubMed ID: 287201 [TBL] [Abstract][Full Text] [Related]
40. Central diabetes insipidus preceding acute myeloid leukemia with t(3;12)(q26;p12). Nieboer P; Vellenga E; Adriaanse R; van de Loosdrecht AA Neth J Med; 2000 Feb; 56(2):45-7. PubMed ID: 10710939 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]